Daehan New Pharm Co. Ltd (054670) — Long-term Investment Intensity
Daehan New Pharm Co. Ltd (054670) has a Long-term Investment Intensity of 26.2% as of September 2018. Long-term investments of ₩30.87 Billion represent 26.2% of total assets of ₩117.93 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Daehan New Pharm Co. Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Daehan New Pharm Co. Ltd Long-term Investment Intensity (2014–2017)
This chart shows how Daehan New Pharm Co. Ltd's Long-term Investment Intensity has evolved across 4 annual periods from 2014 to 2017. As of September 2018, the intensity stands at 26.2%, reflecting long-term investments of ₩30.87 Billion against total assets of ₩117.93 Billion KRW. Explore 054670 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Daehan New Pharm Co. Ltd (2014–2017)
The table below presents the year-by-year Long-term Investment Intensity for Daehan New Pharm Co. Ltd from 2014 to 2017, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Daehan New Pharm Co. Ltd market cap and net worth.
| Year | LT Investment Intensity | LT Investments (KRW) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2017 | 27.2% | ₩33.09 Billion | ₩121.82 Billion | ▲ +1.2 pp |
| 2016 | 25.9% | ₩33.88 Billion | ₩130.72 Billion | ▼ -8.4 pp |
| 2015 | 34.3% | ₩45.53 Billion | ₩132.63 Billion | ▼ -0.8 pp |
| 2014 | 35.1% | ₩45.83 Billion | ₩130.47 Billion | — |